Effects of finerenone on cardiorenal outcomes in blood pressure subgroups in patients with CKD and T2D

Simple item page
dc.contributor.authorRuilope Urioste, Luis Miguel
dc.contributor.authorAgarwal, Rajiv L.
dc.contributor.authorAnker, Stefan D.
dc.contributor.authorFilippatos, Gerasimos S.
dc.contributor.authorPitt, Bertram
dc.contributor.authorRossing, Peter
dc.contributor.authorSarafidis, Pantelis A.
dc.contributor.authorSchmieder, Roland
dc.contributor.authorJoseph, Amer
dc.contributor.authorBakris, George
dc.contributor.authorEt al.
dc.date.accessioned2022-01-15T15:28:14Z
dc.date.available2022-01-15T15:28:14Z
dc.date.issued2021
dc.description.filiationUEMspa
dc.description.impact7.186 JCR (2021) Q1, 3/25 Transplantationspa
dc.description.impact1.536 SJR (2021) Q1, 7/72 Nephrologyspa
dc.description.impactNo data IDR 2021spa
dc.description.sponsorshipSin financiaciónspa
dc.identifier.citationRuilope, L., Agarwal, R., Anker, S. D., Filippatos, G., Pitt, B., Rossing, P., Sarafidis, P., Schmieder, R. E., Joseph, A., Mentenich, N., Nowack, C., & Bakris, G. (2021). Effects of finerenone on cardiorenal outcomes in blood pressure subgroups in patients with CKD and T2D. Nephrology Dialysis Transplantation, 36(1), FC090.spa
dc.identifier.issn0931-0509
dc.identifier.issn1460-2385
dc.identifier.urihttp://hdl.handle.net/11268/10568
dc.language.isoengspa
dc.peerreviewedSispa
dc.rights.accessRightsrestricted accessspa
dc.subject.otherFallo renal crónicospa
dc.subject.otherDiabetes mellitus tipo 2spa
dc.subject.unescoSistema endocrinospa
dc.subject.unescoEnfermedad cardiovascularspa
dc.subject.unescoTratamiento médicospa
dc.titleEffects of finerenone on cardiorenal outcomes in blood pressure subgroups in patients with CKD and T2Dspa
dc.typeconference outputspa
dspace.entity.typePublication

Files

Collections

Otras Áreas de Actividad Física y Deporte